Home > Healthcare > Medical Devices > Implantable Devices > Neuroprosthetics Market

Neuroprosthetics Market Size

  • Report ID: GMI12748
  • Published Date: Dec 2024
  • Report Format: PDF

Neuroprosthetics Market Size

The global neuroprosthetics market size was valued at USD 15.5 billion in 2024 and is expected to exhibit growth at a CAGR of 12.7% from 2025 to 2034 period. The market growth is attributed to the rise in the prevalence of neurological disorders and the growing adoption of wearable neuroprosthetics.   

 

As the global population ages, neurodegenerative diseases such as Parkinson and Alzheimer are on the rise. According to the World Health Organization (WHO), over 55 million people worldwide were living with dementia in 2023, with nearly 10 million new cases reported annually. This growing burden has led to an increased reliance on deep brain stimulation devices which aid in restoring motor functions or alleviating sensory losses, thereby driving the adoption of neuroprosthetic devices.
 

Furthermore, growing awareness of the benefits of neuroprosthetics among healthcare providers and patients, coupled with improving healthcare access in emerging markets, is further driving market growth. Government initiatives and funding for neurological health also contribute to the expansion of neuroprosthetic applications.  
 

Neuroprosthetics refers to biomedical devices that interface with the nervous system to restore lost sensory, motor, or cognitive functions. These devices work by stimulating or recording signals from the brain, spinal cord, or peripheral nerves.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global neuroprosthetics industry was valued at USD 15.5 billion in 2024 and is projected to grow at a CAGR of 12.7% from 2025 to 2034, driven by the increasing prevalence of neurological disorders and the adoption of wearable neuroprosthetics.

The motor prosthetics segment is expected to grow at a CAGR of 12.5%, reaching over USD 23 billion by 2034, supported by advancements in brain-machine interfaces (BMIs) and neural control interfaces that enhance functionality and accuracy.

The U.S. neuroprosthetics market was valued at USD 6.6 billion in 2024 and is anticipated to grow at a CAGR of 12% from 2025 to 2034, driven by a significant aging population and the rising prevalence of neurological disorders such as Parkinson's disease and epilepsy.

Key players in the market include Advanced Bionics, Boston Scientific, Cochlear, Kernel, LivaNova, Med-El, Medtronic, NDI, Neuropace, Nevro, Retina Implant, and Second Sight.

Neuroprosthetics Market Scope

Buy Now


Premium Report Details

  • Base Year: 2024
  • Companies covered: 13
  • Tables & Figures: 206
  • Countries covered: 19
  • Pages: 135
 Download Free Sample